Correlation Between Cingulate and Endonovo Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cingulate and Endonovo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate and Endonovo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cingulate and Endonovo Therapeutics, you can compare the effects of market volatilities on Cingulate and Endonovo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate with a short position of Endonovo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate and Endonovo Therapeutics.

Diversification Opportunities for Cingulate and Endonovo Therapeutics

-0.25

Correlation Coefficient

Cingulate  Endonovo Therapeutics

Very good diversification

The 3 months correlation between Cingulate and Endonovo is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate and Endonovo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Endonovo Therapeutics and Cingulate is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate are associated (or correlated) with Endonovo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Endonovo Therapeutics has no effect on the direction of Cingulate i.e., Cingulate and Endonovo Therapeutics go up and down completely randomly.

Pair Corralation between Cingulate and Endonovo Therapeutics

Given the investment horizon of 90 days Cingulate is expected to generate 1.52 times less return on investment than Endonovo Therapeutics. But when comparing it to its historical volatility, Cingulate is 7.23 times less risky than Endonovo Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Endonovo Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  0.07  in Endonovo Therapeutics on October 9, 2024 and sell it today you would lose (0.03) from holding Endonovo Therapeutics or give up 42.86% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cingulate  vs.  Endonovo Therapeutics

Cingulate

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cingulate are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Cingulate reported solid returns over the last few months and may actually be approaching a breakup point.

Endonovo Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Endonovo Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting fundamental indicators, Endonovo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cingulate and Endonovo Therapeutics

The main advantage of trading using opposite Cingulate and Endonovo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate position performs unexpectedly, Endonovo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endonovo Therapeutics will offset losses from the drop in Endonovo Therapeutics' long position.

The idea behind Cingulate and Endonovo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.